BMRN - Financial Reports List - BioMarin Pharmaceutical Inc. - IntrinsicAlpha

BioMarin Pharmaceutical Inc. BMRN

Healthcare - Biotechnology - NASDAQ - US

$ 59.16

-1.83 %

$ 11.3 B

Market Cap

26.77

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	15.65%	513.22%	1035.15%
Annual Report	FY	10-K	2024-12-31	17.97%	154.62%	149.03%
Quarterly Report	Q3	8-K	2024-09-30	27.27%	162.72%	398.87%
Quarterly Report	Q2	8-K	2024-06-30	19.18%	91.25%	82.24%
Quarterly Report	Q1	8-K	2024-03-31	9.43%	74.35%	35.39%
Quarterly Report	Q4	8-K	2023-12-31	20.22%	8282.73%	202.06%
Annual Report	FY	10-K	2023-12-31	15.42%	18.43%	237.89%
Quarterly Report	Q3	8-K	2023-09-30	15.95%	707.01%	722.70%
Quarterly Report	Q2	8-K	2023-06-30	11.39%	102.57%	45.00%
Quarterly Report	Q1	8-K	2023-03-31	14.17%	-57.90%	101.60%

1